Effect of Sulfinpyrazone on Ventricular Arrhythmia, Prostaglandin Synthesis, and Catecholamine Release Following Coronary Artery Occlusion in the Cat

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  1982-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-198211000-00030PMID 6185774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of sulfinpyrazone on the response to sympathetic nervous system stimulation.

  1982cited by this paper
• THE EFFECTS OF PROSTAGLANDINS E2, F2α, PROSTACYCLIN, FLURBIPROFEN AND ASPIRIN ON ARRHYTHMIAS RESULTING FROM CORONARY ARTERY LIGATION IN ANAESTHETIZED RATS

  1981cited by this paper
• Effect of Prostaglandin Synthesis Inhibition and Sympathectomy on Ouabain‐Induced Arrhythmia in Cats

  1981cited by this paper
• Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias

  1981cited by this paper
• Sulfinpyrazone in the prevention of sudden death after myocardial infarction.

  1980cited by this paper
• Chronic use of aspirin versus indomethacin during non-thrombotic myocardial ischemia: effects on survival.

  1980cited by this paper
• The cat as a model for myocardial infarction.

  1979cited by this paper
• The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.

  1979cited by this paper
• Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium.

  1979cited by this paper
• Comparison of the effects of prostaglandins E1 and A1 on coronary occlusion induced arrhythmia.

  1979cited by this paper
• Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine.

  1978cited by this paper
• Quantitation of anterior descending vs. circumflex venous drainage in the canine great cardiac vein and coronary sinus.

  1978cited by this paper
• Chemical stability of prostacyclin (PGI2) in aqueous solutions.

  1978cited by this paper
• Antiarrhythmic Effects of Aspirin during Nonthrombotic Coronary Occlusion

  1978cited by this paper
• Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart

  1977cited by this paper
• Basic mechanisms of prostaglandin action on autonomic neurotransmission.

  1977cited by this paper
• The influence of prostaglandins E1 and E2 on ouabain cardiotoxicity in the cat.

  1977cited by this paper
• Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.

  1977cited by this paper
• Regional Cardiac Prostaglandin Release during Myocardial Ischemia in Anesthetized Dogs

  1976cited by this paper
• Effects of prostaglandins on experimental arrhythmias.

  1974cited by this paper
• Prostaglandins as modulators of the autonomic nervous system.

  1974cited by this paper
• A simplified radiometric assay for plasma norepinephrine and epinephrine.

  1973cited by this paper
• The influence of PGF2 alpha on experimental arrhythmias.

  1973cited by this paper
• Effect of prostaglandin E1 on ouabain-induced arrhythmia.

  1973cited by this paper
• Prostaglandin E 1 and cardiac arrhythmia.

  1972cited by this paper
• Role of the nervous system in the arrhythmias produced by coronary occlusion in the cat.

  1971cited by this paper
• THE RELEASE OF PROSTAGLANDINS FROM LUNG AND OTHER TISSUES

  1971cited by this paper
• A sympathetic reflex elicited by experimental coronary occlusion.

  1969cited by this paper
• Studies on the mechanism of the hypertensive effect of prostaglandin F2-alpha.

  1968cited by this paper
• Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction.

  1967cited by this paper
• Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity.

  1963cited by this paper

• Biochemical Mediators of Ventricular Arrhythmias in Ischemic Heart Disease

  2003cites this paper
• Contribution of Eicosanoids in the Heart

  1999cites this paper
• Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease.

  1993cites this paper
• Eicosanoids and Arrhythmogenesis

  1989cites this paper
• A direct role of endogenous prostaglandins in reperfusion-induced cardiac arrhythmias.

  1989cites this paper
• Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat.

  1988cites this paper
• Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.

  1987cites this paper
• The vagal involvement in the antiarrhythmic and arrhythmogenic effects of prostaglandin F2 alpha on ouabain-induced cardiac arrhythmias in cats.

  1987cites this paper
• Efficacy of the antidepressant iprindole against experimental arrhythmias.

  1986cites this paper
• Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.

  1986cites this paper
• Dose‐related cardiac electrophysiologic effects of sulfinpyrazone

  1985cites this paper
• Neutrophil Depletion Suppresses 111In-Labeled Platelet Accumulation in Infarcted Myocardium

  1985cites this paper
• Arrhythmias associated with myocardial ischaemia and infarction.

  1985cites this paper
• Effects of chronic metoprolol and sulphinpyrazone on human lymphocyte beta-adrenoceptors.

  1984cites this paper
• Sulfinpyrazone increases the number of β‐adrenoceptors on intact human lymphocytes

  1984cites this paper